Stallion India

Why is Stallion India Fluorochemicals Ltd falling/rising?

As of 14-Jun, Stallion India Fluorochemicals Ltd's stock price is rising to Rs 183.30, up 6.17%, following a trend reversal. The stock has shown significant growth over the past month and year, driven by strong fundamentals and increased institutional investor participation, despite a recent decline in delivery volume.

As of 14-Jun, Stallion India Fluorochemicals Ltd's stock price is rising, currently at Rs 183.30, reflecting an increase of Rs 10.65 or 6.17%. This upward movement follows a trend reversal after two consecutive days of decline. The stock has outperformed its sector by 4.33% today and reached an intraday high of Rs 184.3, indicating strong market interest.<BR><BR>Despite a recent decline of 3.70% over the past week, the stock has shown impressive growth over the last month, with a return of 24.61%. Over the past year, it has achieved a remarkable 169.56% return, significantly outperforming the broader market, which has seen a negative return of 7.55%. <BR><BR>The positive momentum can also be attributed to the company's net-debt-free status and healthy long-term growth, as evidenced by an annual operating profit growth rate of 61.09%. Additionally, there has been an increase in participation from institutional investors, who have raised their stake by 4.68% in the previous quarter, indicating confidence in the company's fundamentals.<BR><BR>However, it is important to note that there has been a decline in investor participation, with delivery volume falling by 8.29% against the 5-day average. Despite this, the stock remains liquid enough for trading, suggesting that the current rise is supported by a combination of strong fundamentals and institutional interest.

Which are the latest news on Stallion India?

What does Stallion India do?

Stallion India Fluorochemicals Ltd, a Micro Cap company established in 2002 and converted to a Public Limited Company in 2023, operates in the Other Chemical products industry, reporting net sales of 110 Cr and a net profit of 11 Cr for Q1 2026. Key metrics include a P/E of 48.00 and a market cap of INR 2,157 Cr.

Overview:<BR>Stallion India Fluorochemicals Ltd operates in the Other Chemical products industry and is classified as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated in 2002 as a Private Limited Company and later converted to a Public Limited Company in 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 110 Cr (Quarterly Results - Mar 2026)<BR>Net Profit: 11 Cr (Quarterly Results - Mar 2026)<BR>Market Cap: INR 2,157 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 48.00<BR>Industry P/E: 42<BR>Dividend Yield: 0.00%<BR>Debt Equity: -0.59<BR>Return on Equity: 6.44%<BR>Price to Book: 3.19<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Stallion India?

As of 10th June, Stallion India Fluorochemicals Ltd has a market capitalization of 2,157.00 Cr, with recent net sales of 430.67 Cr and a net profit of 43.84 Cr.

As of 10th June, Stallion India Fluorochemicals Ltd has a market capitalization of 2,157.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Stallion India reported Net Sales of 430.67 Cr and a Net Profit of 43.84 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 300.84 Cr and Total Assets of 327.21 Cr.

Who are the peers of the Stallion India?

Stallion India's peers include Linde India, PCBL Chemical, Refex Industries, and others, with varying management risks and growth rates. Stallion India leads in 1-year returns at 168.05%, significantly outperforming its peers.

Peers: The peers of Stallion India are Linde India, PCBL Chemical, Refex Industries, Ellen.Indl.Gas, Prem. Explosives, GOCL Corpn., Keltech Energies, DIC India, and Monolithisch Ind.<BR><BR>Quality Snapshot: Excellent management risk is observed at Linde India, while Good management risk is found at PCBL Chemical. Average management risk is present at Refex Industries, Ellen.Indl.Gas, Prem. Explosives, GOCL Corpn., Keltech Energies, DIC India, and Monolithisch Ind, and the rest. Below Average management risk is noted for Stallion India. Growth is Excellent at Refex Industries and Monolithisch Ind, Good at PCBL Chemical, Prem. Explosives, and Keltech Energies, Average at Ellen.Indl.Gas and GOCL Corpn., Below Average at Linde India, and the rest. Capital Structure is Excellent at Linde India and Stallion India, Good at Refex Industries, Ellen.Indl.Gas, Prem. Explosives, and Keltech Energies, Average at PCBL Chemical, and Below Average at GOCL Corpn. and DIC India.<BR><BR>Return Snapshot: Stallion India has the highest 1-year return at 168.05%, while PCBL Chemical has the lowest at -31.45%. Stallion India's return significantly exceeds all peers, and the peers with negative six-month returns are Linde India, Refex Industries, Ellen.Indl.Gas, and DIC India.

Should I buy, sell or hold Stallion India Fluorochemicals Ltd?

Are Stallion India Fluorochemicals Ltd latest results good or bad?

Stallion India Fluorochemicals Ltd's latest results are mixed, with a net profit decline of 17.64% year-on-year and a significant revenue drop of 27.43%, raising concerns about demand sustainability. While there was a 40.08% profit growth over nine months, the sharp revenue contraction and stock decline indicate investor skepticism about future growth.

The latest results for Stallion India Fluorochemicals Ltd indicate a mixed performance. In Q4 FY26, the company reported a net profit of ₹10.93 crores, which is a decline of 17.64% year-on-year and a slight decrease of 1.80% quarter-on-quarter. Revenue for the same quarter was ₹109.99 crores, reflecting a significant year-on-year decline of 27.43%, although it showed a modest sequential growth of 5.10%.<BR><BR>While the operating margin improved to 14.86%, up 370 basis points from the previous quarter, the overall revenue contraction raises concerns about the sustainability of demand. The company's stock has also seen a dramatic decline of 61.13% from its 52-week high, reflecting investor apprehension regarding its growth prospects in a competitive market.<BR><BR>On a more positive note, the nine-month performance for FY26 showed a net profit growth of 40.08% compared to the previous year, indicating some resilience in the business. However, the elevated valuation metrics, with a P/E ratio of 35.23 and a price-to-book ratio of 5.12, suggest limited room for error in execution.<BR><BR>Overall, the results can be characterized as concerning, particularly due to the sharp revenue decline and the market's reaction, which reflects skepticism about the company's ability to maintain its growth trajectory. Investors should be cautious and monitor upcoming quarters for signs of stabilization and recovery.

When is the next results date for Stallion India Fluorochemicals Ltd?

The next results date for Stallion India Fluorochemicals Ltd is 13 May 2026.

The next results date for Stallion India Fluorochemicals Ltd is scheduled for 13 May 2026.

Is Stallion India overvalued or undervalued?

As of November 26, 2025, Stallion India is considered overvalued with a PE ratio of 45.93, an EV to EBITDA of 29.40, and a PEG ratio of 0.00, significantly higher than its peers and has underperformed against the Sensex with a 1-month return of -41.72%.

As of 26 November 2025, Stallion India has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.93, an EV to EBITDA of 29.40, and a ROCE of 19.73%. <BR><BR>In comparison to its peers, Stallion India's PE ratio is significantly higher than Godrej Industries, which stands at 36.8, and Deepak Nitrite at 40.22. The PEG ratio for Stallion is 0.00, indicating no growth expectations priced into the stock, which is concerning given its high valuation. Additionally, Stallion India has underperformed against the Sensex, with a 1-month return of -41.72% compared to the Sensex's 1.66% return, further reinforcing the notion that the stock may be overvalued.

How has been the historical performance of Stallion India?

Stallion India has shown significant growth over the past three years, with net sales increasing from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, and profit after tax rising from 9.75 Cr to 32.33 Cr, reflecting strong operational efficiency and profitability. Total assets also grew substantially, indicating robust financial performance across key metrics.

Answer:<BR>The historical performance of Stallion India shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Stallion India's net sales increased from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, indicating a strong upward trend. Total operating income followed suit, rising from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25. The company's total expenditure also grew, from 210.46 Cr in Mar'23 to 329.73 Cr in Mar'25, primarily driven by raw material costs, which surged from 195.58 Cr to 292.95 Cr during the same period. Operating profit (PBDIT) saw a substantial rise from 15.60 Cr in Mar'23 to 49.74 Cr in Mar'25, reflecting improved operational efficiency. Profit before tax increased from 12.97 Cr to 42.43 Cr, while profit after tax rose from 9.75 Cr to 32.33 Cr, showcasing a robust growth in profitability. The earnings per share (EPS) also improved significantly, from 1.77 in Mar'23 to 4.08 in Mar'25. On the balance sheet, total assets grew from 125.43 Cr in Mar'23 to 327.21 Cr in Mar'25, with total liabilities increasing from 125.43 Cr to 327.21 Cr as well. The cash flow from financing activities remained positive, contributing to a net cash inflow of 42.00 Cr in Mar'25, up from 15.00 Cr in Mar'24. Overall, Stallion India has demonstrated a strong financial performance with consistent growth across key metrics.

Who are the top shareholders of the Stallion India?

The top shareholder of Stallion India is Shazad Sheriar Rustomji, holding 67.88% of the shares. Other shareholders include 12 Foreign Institutional Investors with 3.32%, Geetu Yadav as the highest public shareholder at 4.16%, and individual investors holding 16.94%, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Stallion India are primarily the promoters, with Shazad Sheriar Rustomji holding the largest share at 67.88%. In addition to the promoters, there are 12 Foreign Institutional Investors (FIIs) collectively holding 3.32% of the company. The highest public shareholder is Geetu Yadav, who owns 4.16%. Individual investors account for 16.94% of the total shareholding. Notably, there are no pledged promoter holdings and no mutual funds currently holding shares in the company.

Has Stallion India declared dividend?

No Dividend History Available